Company news
Creative Medical Technology Holdings, Inc. news in 2020
Creative Medical Technology Holdings, Inc.'s news releases, calls and decks from 2020, newest first.
Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz® Regenerative Immunotherapy
December 30, 2020
Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz® Personalized Cellular Immunotherapy in Preclinical Model
December 28, 2020
Creative Medical Technology Holdings Identifies Mechanism of Action of ImmCelz® Stroke Regenerative Activity
December 21, 2020
Creative Medical Technology Holdings Announces Successful Application of ImmCelz® Immunotherapy for Treatment of Stroke
December 15, 2020
Creative Medical Technology Holdings files Patent on Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz® Cellular Immunotherapy
December 9, 2020
Creative Medical Technology Holdings Reports Positive Preclinical Data on ImmCelz® Immunotherapy Product in Rheumatoid Arthritis Model
September 28, 2020
Creative Medical Technology Holdings, Inc. September 2020 Shareholder Update
September 23, 2020
Creative Medical Technology Holdings Identifies Novel Mechanism of Action of AmnioStem™ Adult Stem Cell Product in Stroke
August 19, 2020
Creative Medical Technology Holdings Completes AmnioStem™ Preclinical Studies Needed for FDA Investigational New Drug Application Filing
July 8, 2020
Creative Medical Technology Holdings is Granted Patent on Mesenchymal Stem Cells for Female Infertility Pending Quayle Action
April 19, 2020
Creative Medical Technology Holdings Announces IMMCELZ™ Adoptive Immunotherapy Product
March 10, 2020